1 / 16

Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer

Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer. Program Goals. Changes to the Standard of Care for HER2-Positive Disease. CLEOPATRA Trial Results. CLEOPATRA Updated Overall Survival Analysis. Administering Dual HER2 Blockade.

colt-ellis
Télécharger la présentation

Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Single vs Dual HER2 Blockade for Metastatic HER2-Positive Breast Cancer

  2. Program Goals

  3. Changes to the Standard of Care for HER2-Positive Disease

  4. CLEOPATRA Trial Results

  5. CLEOPATRAUpdated Overall Survival Analysis

  6. Administering Dual HER2 Blockade

  7. Are All Patients Candidates for Dual HER2 Blockade?

  8. Pertuzumab /Trastuzumab /DocetaxelSafety Profile

  9. Approaches in Different Scenarios

  10. Neoadjuvant Therapy

  11. Surgery in a Patient With Stage IV Breast Cancer

  12. Investigational Trials

  13. Abbreviations

  14. References

  15. References (cont)

  16. References (cont)

More Related